Displaying 26–50 of 249 results for Paul Thomas, Senior Editor

Sort By Relevance Sort By Date
1 2 3 4 5 ...10

Pharma Workers Enter the Era of Free Agency

(Article)

Tectonic shifts are changing the way pharma workers will view loyalty and employment, says Kelly Services’ Alan Edwards.

Derek Lowe: Where Are Pharma’s Jobs Going?

(Article)

Insights on the 2012 job market from an industry insider.

Optimizing the Roche-Genentech Biologics Network

(Article)

VP David Chang shares insights on strategy, as well as tech transfer best practices.

Pfizer: Moving from Centralized to Holistic Supply Chain Security

(Article)

When it comes to patient safety, says Brian Johnson, there should be no “competitive advantage.”

Technology Roundup: Machine Vision Insight Aids Operational Oversight

(Article)

Pharmaceutical machine vision technologies are getting simpler and cheaper, and yet tackling more varied applications.

John Challenger: Cross-Currents Buffeting Pharma Make Predicting 2012 Job ...

(Article)

We have a ways to go before any kind of equilibrium is established in the pharma workforce, the job market guru says.

On Shire, Single-Use and Simplicity

(Article)

CRB’s Eric Unrau talks about what worked at Shire Lexington, and what limitations need to be overcome for single-use systems.

PharmaView: Coming to America: European Companies Buy In and Lease

(Article)

"OUS" companies are enjoying the U.S. market, and creating a few jobs along the way.

PharmaView: Can Manufacturing Be Sexy for Millennials?

(Article)

If not, maybe greed can help overcome manufacturing’s PR problem with young professionals.

Groundbreakers: Tomorrow's Drug Manufacturing Facilities

(Article)

Modular construction and disposable process equipment are maximizing agility and minimizing risk.

Split Decisions: Tablet Scoring Under More Scrutiny

(Article)

FDA provides more direction as questions arise about dosage consistency.

Modular Construction in Pharma: No Longer a Novelty

(Article)

Modularly constructed facilities are becoming less expensive, and more practical, for small and large drug manufacturers alike.

Drug Manufacturers Seek Remote Control

(Article)

Videoconferencing amongst manufacturing professionals is easing everything from tech transfer to troubleshooting.

Biopharma’s Future Facilities: Smaller Footprints, Complexities, and Costs

(Article)

A talk with Hyde’s Peter Watler about trends shaping biopharma facilities today and tomorrow.

MedImmune in Frederick: Using Ordinary Tools in Extraordinary Ways

(Article)

MedImmune’s approach may help take the blame off automation for plant startup delays.

Pharma Facilities: Modular Gains Momentum

(Article)

While modular drug facilities have had inconsistent results to date, they are an inevitable part of pharma’s future. We speak with modular construction expert Pär Almhem.

PharmaView: Fake Drugs: Why Business is Booming

(Article)

It’s time to make counterfeiting less economically tantalizing.

Rating Pharma Contract Manufacturers: Does Perception Equal Reality?

(Article)

A look at data on how the industry chooses with whom to outsource, and what it really thinks about potential partners.

Solvent Recovery at Pfizer: A Continuous Solution for Small Waste Streams

(Article)

When equipment and processes challenge solvent recovery for small-volume streams, an atypical approach is needed, says Pfizer’s Frank Urbanski.

Materials ID: The More the Merrier in the Handheld Device Market?

(Multimedia)

Capable new Raman-based and other handheld technologies are proliferating as drug manufacturers see the need for quick, mobile raw materials inspection capabilities.

PharmaView: Are Unions (Love 'Em or Not) the Last Bastion for Pharma Job ...

(Article)

Communities can partner with manufacturers, but they can’t apply pressure.

Quality: Toward a Multidimensional View

(Article)

Pharma Tech Industries’ Preston Wright talks about the need to move to a “consistent quality presence that is both efficient and effective.”

Process Validation Guidance: A Bad Fit for Aseptic Processing?

(Article)

“Science-based” is well and good, but FDA’s guidance may create confusion.

RMM Roundup: A Focus on Fast

(Article)

Rapid microbiological methods continue to be developed in order to support or supplant compendial methods.

Sort By Relevance Sort By Date
1 2 3 4 5 ...10